Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

The Effect of Concizumab Prophylaxis on Target Joints, Resolution and Joint Bleeds in Patients With Hemophilia A or B With or Without Inhibitors in Phase 3 Clinical Trials

Giancarlo Castaman, Aby Abraham, Pantep Angchaisuksiri, Laura Villarreal Martinez, Keiji Nogami, Jameela Sathar, Chunduo Shen, Jay Jay Thaung Zaw, Guy Young

Blood (2023) 142 (Supplement 1): 284.

https://doi.org/10.1182/blood-2023-180790

Published: 2023

Journal Articles

Long-Term Durable FVIII Expression with Improvements in Bleeding Rates Following AAV-Mediated FVIII Gene Transfer for Hemophilia A: Multiyear Follow-up on the Phase I/II Trial of SPK-8011

Blood (2022) 140 (Supplement 1): 1899–1901.

https://doi.org/10.1182/blood-2022-158903

Published: 2022

Journal Articles

Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results

Amy D. Shapiro, Pantep Angchaisuksiri, Jan Astermark, Gary Benson, Giancarlo Castaman, Pratima Chowdary, Hermann Eichler, Victor Jiménez-Yuste, Kaan Kavakli, Tadashi Matsushita, Lone Hvitfeldt Poulsen, Allison P. Wheeler, Guy Young, Silva Zupancic-Salek, Johannes Oldenburg

Blood (2019) 134 (22): 1973–1982.

https://doi.org/10.1182/blood.2019001542

Published: 2019

Includes: Multimedia, Supplemental data

Journal Articles

Efficacy and Safety of Subcutaneous Prophylaxis with Concizumab in Patients with Severe Hemophilia a without Inhibitors: Results from the Phase 2 explorer5 Trial

Hermann Eichler, Pantep Angchaisuksiri, MD, Jan Astermark, MD PhD, Gary Benson, Katarina Cepo, Pratima Chowdary, MD, Ute Friedrich, PhD, Kaan Kavakli, Allison P Wheeler, MD, Johannes Oldenburg, MD PhD

Blood (2019) 134 (Supplement_1): 2417.

https://doi.org/10.1182/blood-2019-122300

Published: 2019

Journal Articles

Concizumab (Anti-TFPI) Exposure-Response Modeling in Patients with Hemophilia A

Hermann Eichler, MD, Pantep Angchaisuksiri, MD, Kaan Kavakli, MD, Paul Knöbl, MD PhD, Jerzy Windyga, Victor Jimenez-Yuste, Ute Friedrich, PhD, Philip Delff Andersen, Pratima Chowdary

Blood (2017) 130 (Supplement 1): 3672.

https://doi.org/10.1182/blood.V130.Suppl_1.3672.3672

Published: 2017

Journal Articles

International ITP Registry with Focus on the Asia Pacific Region: Update on Preliminary Findings of Epidemiological and Clinical Data

Beng H Chong, MBBS, PhD, Jong-Wook Lee, MD, Jun Ho Jang, MD PhD, Tzeon-Jye Chiou, MD, Lai Heng Lee, Osman Ilhan, MD, Pantep Angchaisuksiri, MD, Ai-Sim Goh, Soo Chin Ng, FRCP, Shinichiro Okamoto, MD, Kenny Mauricio Galvez, Sarah Davidson, RN

Blood (2017) 130 (Supplement 1): 4853.

https://doi.org/10.1182/blood.V130.Suppl_1.4853.4853

Published: 2017

Journal Articles

ITP Patients in the Asia Pacific: Are They Different?

Beng H Chong, MBBS, PhD, Jong-Wook Lee, MD, Jun Ho Jang, MD PhD, Tzeon-Jye Chiou, MD, Lai Heng Lee, Osman Ilhan, MD, Pantep Angchaisuksiri, MD, Kenny Mauricio Galvez, Ai-Sim Goh, Soo Chin Ng, FRCP, Shinichiro Okamoto, MD, Sarah Davidson, RN

Blood (2017) 130 (Supplement 1): 4862.

https://doi.org/10.1182/blood.V130.Suppl_1.4862.4862

Published: 2017

Journal Articles

Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial

Peter W. Collins, Guy Young, Karin Knobe, Faraizah Abdul Karim, Pantep Angchaisuksiri, Claus Banner, Türkiz Gürsel, Johnny Mahlangu, Tadashi Matsushita, Eveline P. Mauser-Bunschoten, Johannes Oldenburg, Christopher E. Walsh, Claude Negrier

Blood (2014) 124 (26): 3880–3886.

https://doi.org/10.1182/blood-2014-05-573055

Published: 2014

Includes: Supplemental data

Journal Articles

Edoxaban For Long-Term Treatment Of Venous Thromboembolism In Cancer Patients

Gary E Raskob, PhD, Harry Buller, MD, PhD, Pantep Angchaisuksiri, MD, Doyeun Oh, MD, PhD, Zoltan Boda, MD, PhD, DSc, Roger M. Lyons, MD, Jeffrey I. Weitz, MD, George Zhang, PhD, Hans J Lanz, MD, Michele Mercuri, MD, PhD, FAHA

Blood (2013) 122 (21): 211.

https://doi.org/10.1182/blood.V122.21.211.211

Published: 2013

Journal Articles

Establishment of Carrier Detection and Prenatal Diagnosis Service for Hemophilia in a Developing Country: Experience From International Hemophilia Training Center-Bangkok.

Ampaiwan Chuansumrit, MD, Nongnuch Sirachainan, MD, Pantep Angchaisuksiri, MD, Werasak Sasanakul, Pakawan Wongwerawattanakoon, B.Sc., Praguywan Kadegasem, B.Sc., Patama Promsonthi, Hathaiwut Lamthean

Blood (2012) 120 (21): 3162.

https://doi.org/10.1182/blood.V120.21.3162.3162

Published: 2012

Journal Articles

Splenectomy Exacerbates the Hypercoagulable State and Causes Significant Organ Dysfunction in Patients with Hemoglobin E/β-Thalassemia.

Vichai Atichartakarn, MD, Suporn Chuncharunee, MD, Napaporn Archararit, Umaporn Udomsubpayakul, Atiporn Ingsathit, MD, Ratchanee Lee, MD, Anusith Tunhasiriwet, MD, Supachai Tanomsup, MD, Katcharin Aryurachai, Artit Ungkanont, MD, Pimjai Niparuck, MD, Pantep Angchaisuksiri, MD

Blood (2009) 114 (22): 2014.

https://doi.org/10.1182/blood.V114.22.2014.2014

Published: 2009

Journal Articles

Prevalence and Predictors of Pulmonary Arterial Hypertension in Hemoglobin E/ β-Thalassemia Patients.

Suporn Chuncharunee, MD, Vichai Atichartakarn, MD, Napaporn Archararit, Umaporn Udomsubpayakul, Atiporn Ingsathit, MD, Ratchanee Lee, MD, Anusith Tunhasiriwet, MD, Supachai Tanomsup, MD, Katcharin Aryurachai, Artit Ungkanont, MD, Pimjai Niparuck, MD, Pantep Angchaisuksiri, MD

Blood (2009) 114 (22): 2015.

https://doi.org/10.1182/blood.V114.22.2015.2015

Published: 2009

Journal Articles

Secretion of a unique peptide from interleukin-2–stimulated natural killer cells that induces endomitosis in immature human megakaryocytes

Pantep Angchaisuksiri, Shawn R. Grigus, Patricia L. Carlson, Geoffrey W. Krystal, Emmanuel N. Dessypris

Blood (2002) 99 (1): 130–136.

https://doi.org/10.1182/blood.V99.1.130

Published: 2002

NARROW

The Effect of Concizumab Prophylaxis on Target Joints, Resolution and Joint Bleeds in Patients With Hemophilia A or B With or Without Inhibitors in Phase 3 Clinical Trials

Long-Term Durable FVIII Expression with Improvements in Bleeding Rates Following AAV-Mediated FVIII Gene Transfer for Hemophilia A: Multiyear Follow-up on the Phase I/II Trial of SPK-8011

Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results

Efficacy and Safety of Subcutaneous Prophylaxis with Concizumab in Patients with Severe Hemophilia a without Inhibitors: Results from the Phase 2 explorer5 Trial

Concizumab (Anti-TFPI) Exposure-Response Modeling in Patients with Hemophilia A

International ITP Registry with Focus on the Asia Pacific Region: Update on Preliminary Findings of Epidemiological and Clinical Data

ITP Patients in the Asia Pacific: Are They Different?

Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial

Edoxaban For Long-Term Treatment Of Venous Thromboembolism In Cancer Patients

Establishment of Carrier Detection and Prenatal Diagnosis Service for Hemophilia in a Developing Country: Experience From International Hemophilia Training Center-Bangkok.

Splenectomy Exacerbates the Hypercoagulable State and Causes Significant Organ Dysfunction in Patients with Hemoglobin E/β-Thalassemia.

Prevalence and Predictors of Pulmonary Arterial Hypertension in Hemoglobin E/ β-Thalassemia Patients.

Secretion of a unique peptide from interleukin-2–stimulated natural killer cells that induces endomitosis in immature human megakaryocytes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only